Log in

OTCMKTS:CCELCRYO-CELL International Stock Price, Forecast & News

$7.44
-0.43 (-5.46 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.40
Now: $7.44
$7.65
50-Day Range
$6.10
MA: $6.65
$7.87
52-Week Range
$5.10
Now: $7.44
$8.90
Volume3,152 shs
Average Volume1,699 shs
Market Capitalization$58.03 million
P/E Ratio23.25
Dividend YieldN/A
Beta-0.05
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue specimens worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in Oldsmar, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.79 out of 5 stars


Industry, Sector and Symbol

Industry Services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CCEL
CUSIPN/A
Phone813-749-2100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$31.80 million
Cash Flow$0.36 per share
Book Value($0.89) per share

Profitability

Net Income$2.29 million

Miscellaneous

Employees92
Market Cap$58.03 million
Next Earnings Date7/20/2020 (Estimated)
OptionableNot Optionable

Receive CCEL News and Ratings via Email

Sign-up to receive the latest news and ratings for CCEL and its competitors with MarketBeat's FREE daily newsletter.

CRYO-CELL International (OTCMKTS:CCEL) Frequently Asked Questions

How has CRYO-CELL International's stock been impacted by COVID-19 (Coronavirus)?

CRYO-CELL International's stock was trading at $7.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CCEL stock has increased by 3.3% and is now trading at $7.44. View which stocks have been most impacted by Coronavirus.

When is CRYO-CELL International's next earnings date?

CRYO-CELL International is scheduled to release its next quarterly earnings announcement on Monday, July 20th 2020. View our earnings forecast for CRYO-CELL International.

How were CRYO-CELL International's earnings last quarter?

CRYO-CELL International, Inc. (OTCMKTS:CCEL) posted its quarterly earnings data on Tuesday, April, 14th. The company reported $0.07 EPS for the quarter. The firm had revenue of $7.62 million for the quarter. CRYO-CELL International had a negative return on equity of 37.99% and a net margin of 8.50%. View CRYO-CELL International's earnings history.

Has CRYO-CELL International been receiving favorable news coverage?

Media coverage about CCEL stock has trended extremely negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CRYO-CELL International earned a media sentiment score of -4.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View the latest news aboutCRYO-CELL International.

Who are some of CRYO-CELL International's key competitors?

What other stocks do shareholders of CRYO-CELL International own?

Who are CRYO-CELL International's key executives?

CRYO-CELL International's management team includes the following people:
  • Mr. David I. Portnoy, Chairman & Co-CEO (Age 56)
  • Mr. Mark L. Portnoy, Co-CEO & Director (Age 55)
  • Ms. Jill M. Taymans, CFO & VP of Fin. (Age 49)
  • Mr. Oleg Mikulinsky, Chief Information Officer (Age 46)
  • Dr. Merri Buff Mair, Medical Director & Member of Medical & Scientific Team

What is CRYO-CELL International's stock symbol?

CRYO-CELL International trades on the OTCMKTS under the ticker symbol "CCEL."

How do I buy shares of CRYO-CELL International?

Shares of CCEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CRYO-CELL International's stock price today?

One share of CCEL stock can currently be purchased for approximately $7.44.

How big of a company is CRYO-CELL International?

CRYO-CELL International has a market capitalization of $58.03 million and generates $31.80 million in revenue each year. CRYO-CELL International employs 92 workers across the globe.

What is CRYO-CELL International's official website?

The official website for CRYO-CELL International is www.cryo-cell.com.

How can I contact CRYO-CELL International?

CRYO-CELL International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The company can be reached via phone at 813-749-2100.

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.